02/06/2025
5:34 PM | Atara Biotherapeutics (Subject)
Panacea Innovation Ltd (Filed by)
| Form SCHEDULE 13G | |
01/29/2025
3:52 PM | Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
6:36 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2025
3:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
3:00 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
5:04 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
5:04 PM | Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
5:05 PM | Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
4:54 PM | Atara Biotherapeutics (Subject)
Henrich Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
4:55 PM | Atara Biotherapeutics (Subject)
Hyllengren Eric J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for ATRA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Atara Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/18/2024
4:56 PM | Atara Biotherapeutics (Subject)
Murugan Amar (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
4:58 PM | Atara Biotherapeutics (Subject)
Nguyen AnhCo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
5:10 PM | Atara Biotherapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
12:29 PM | Atara Biotherapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
10:24 AM | Atara Biotherapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/15/2024
3:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
4:03 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
5:42 PM | Adiumentum Capital Fund I GP LLC (Reporting)
Adiumentum Capital Fund I LP (Reporting)
Atara Biotherapeutics (Issuer)
Ciongoli Gregory Austin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2024
3:07 PM | Adiumentum Capital Fund I LP (Filed by)
Atara Biotherapeutics (Subject)
| Form SC 13D/A | |
09/04/2024
3:42 PM | Atara Biotherapeutics (Filer)
| Form 424B5 | |
09/03/2024
4:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
5:26 PM | Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:27 PM | Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:27 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:27 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:27 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
5:00 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:10 PM | Atara Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
4:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
3:16 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | Atara Biotherapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
06/20/2024
4:04 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
7:30 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
5:18 PM | Adiumentum Capital Fund I LP (Filed by)
Atara Biotherapeutics (Subject)
| Form SC 13D | |
05/20/2024
7:32 PM | Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
7:33 PM | Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
7:33 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
7:34 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
7:34 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
8:13 PM | Atara Biotherapeutics (Subject)
Henrich Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Trump doesn’t give a damn (Ad) Porter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks”
I recently met with one of Trump’s longest-serving advisors.
We helped put together a plan to help investors capitalize on Trump’s election.
And we found out these 10 stocks are the most likely to boom… Go here now to find out the names of these 10 stocks. |
05/16/2024
8:13 PM | Atara Biotherapeutics (Subject)
Hyllengren Eric J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
8:14 PM | Atara Biotherapeutics (Subject)
Murugan Amar (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
8:14 PM | Atara Biotherapeutics (Subject)
Nguyen AnhCo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
8:15 PM | Atara Biotherapeutics (Subject)
Touchon Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
7:55 PM | Atara Biotherapeutics (Subject)
Nguyen AnhCo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/26/2024
3:20 PM | Atara Biotherapeutics (Filer)
| Form DEFA14A | |
04/26/2024
3:15 PM | Atara Biotherapeutics (Filer)
| Form DEF 14A | |
04/12/2024
3:15 PM | Atara Biotherapeutics (Filer)
Atara Biotherapeutics (Filer)
| Form PRE 14A | |
04/02/2024
5:11 PM | Atara Biotherapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:12 PM | Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:12 PM | Atara Biotherapeutics (Issuer)
Roncarolo Maria Grazia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:12 PM | Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:13 PM | Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
7:40 AM | Atara Biotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
7:35 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
5:18 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:18 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:19 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:16 PM | Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:17 PM | Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
7:17 PM | Atara Biotherapeutics (Subject)
Murugan Amar (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
7:18 PM | Atara Biotherapeutics (Subject)
Hyllengren Eric J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
7:19 PM | Atara Biotherapeutics (Subject)
Henrich Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
7:21 PM | Atara Biotherapeutics (Subject)
Touchon Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
7:13 PM | Atara Biotherapeutics (Subject)
Nguyen Tran (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free ATRA Stock Alerts